Akeso
Registry sponsor category
Industry
- Other names
- Akeso
- Company name
- Akeso
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Website
- https://www.akesobio.com/
- Publicly traded (proxy)
- No
- Listing at source
- Listed
- Wikidata ID
- Q132735866
Related records
Trials (161)
- A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis
- A Clinical Study of AK115 in Healthy Subjects
- A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
- A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)
- A Clinical Study of AK139 in Healthy Subjects
- A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease
- A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)
- A Long-term Study of AK102 in Patients With Hypercholesterolemia
- A Phase 1 Dose Escalation and Expansion Study of AK117
- A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis
- A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis
- A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor
- A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
- A Phase Ia/Ib Open Label,Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors
- A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors
- A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer
- A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
- A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
- A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.